You might be interested in Buzz Hollander’s remarks about Damar Hamlin’s onfield collapse and talk of myocarditis. I want to underwrite this observation:
If someone wishes to make the case against using the mRNA vaccines in this population, at this point in the pandemic, there is absolutely no need to display the sort of indefensible thoughtlessness of using someone in the midst of a life threatening emergency to make the point. We have more than enough quality science to this effect: the myocarditis concern in this cohort is substantial (in this JAMA article out of Canada, a commonly-reported 1/3000 clip), it might be of greater incidence via subclinical cases (a 2% rate in this well-designed study from Thailand), and Pfizer is behind schedule in releasing its Study C4591031 data on subclinical myocarditis after a booster shot in young men.
As I have written many times before, giving young, healthy men the mRNA Covid-19 vaccines is likely a cost:benefit loser due to this risk of post-vaccination myocarditis, especially since the benefit of the current boosters in those with prior infection or at low risk of severe disease appears to be ephemeral and limited. Mandating them is inexcusable for this reason. The NFL has not mandated boosters, appropriately; those few educational institutions still insisting on required boosters for their students this past year have received appropriate heat.
The anecdotes gained from tragedies of athletes collapsing on the pitch are just that: tragic anecdotes. They need to be carefully curated to have any statistical value. To my eyes, that has not been accomplished.
Sixty-four cases, the number NCAA athletes who died of sudden cardiac arrest, is a pretty small domain. Even when you expand the domain past the NFL into all people playing football at any age, the domain is still tremendously small. I’m not sure that any conclusions can reasonably be drawn from such a small sample.
The other observation revolves around the old rule of thumb that when you hear hoofbeats think horses not zebra. Wwhether you think horses or zebras depends on where you are. If you’re in a New York hospital, horses are probably the smart bet. If you’re in the middle of a veldt in Tanzania, zebras might be a smarter guess.
So, where are we? I don’t think we know. The COVID-19 pandemic is still technically in progress and will probably be studied for the next century at least. It may be the better part of a century before we’re able to tell the horses from the zebras.







